Dyslipidemia in Diabetes

This feed focuses on the dyslipidemia, a disorder in lipid metabolism that leads to abnormal levels of lipids in patients with diabetes.

August 9, 2020

Dendrobium officinale polysaccharide ameliorates the liver metabolism disorders of type II diabetic rats

International Journal of Biological Macromolecules
Jingrui YangShaoping Nie
August 9, 2020

Correlation between vitamin D level and coronary artery calcification

Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
Hamidreza SajjadiehShahram Oveisgharan
August 10, 2020

Integrated omics analysis reveals the alteration of gut microbe-metabolites in obese adults

Briefings in Bioinformatics
Rong LiJian Chen
August 11, 2020

Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes

The Journal of Allergy and Clinical Immunology
Stephanie Lovinsky-DesirMeyer Kattan
August 9, 2020
Open Access

Metabolic Syndrome and Prediabetes Among Yemeni School-Aged Children

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Walid SaeedEkram Al-Eryani
August 11, 2020
Open Access

Pattern of coronary arterial lesions amongst Saudi Arabians: a cross-sectional coronary fluoroscopic angiography study

The Pan African Medical Journal
Khalid Hadi AldosariAbdulrahman Mohammed Aldawsari
August 9, 2020

The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention

Postgraduate Medicine
Kamini TrivediJohn R Nelson
August 11, 2020

Preventive Cardiology and Risk Assessment: Beyond LDL

Current Atherosclerosis Reports
Amit Goyal, Leslie Cho
August 9, 2020
Open Access

Prevalence of Metabolic Syndrome According to Causes of Physical Activity Limitation

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Kyujin LeeJi Young Lee

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2020 Meta ULC. All rights reserved